Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation

Farhan Shahid; Daniele Pastori; Francesco Violi; Professor Gregory Lip

doi:10.1016/j.phrs.2018.04.019

Related publications

Article2020

Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN‐AF survey

Monika Kozieł, Stefan Simović, Nikola Pavlović, Milan Nedeljković, Aleksandar Kocijančić, Vilma Paparisto, Ljilja Musić, Elina Trendafilova, Anca Rodica Dan, Šime Manola, Zumreta Kušljugić, Gheorghe‐Andrei Dan, Professor Gregory Lip, Tatjana Potpara

Article2024

Relationship of Warfarin and Apixaban with Vascular Function in Patients with Atrial Fibrillation

Rehan T. Junejo, Dhiraj Gupta, Richard Snowdon, Professor Gregory Lip, James P. Fisher

Article2021

Atrial Fibrillation in Patients with Chronic Kidney Disease

Agnieszka Kotalczyk, Wern Yew Ding, Christopher F. Wong, Anirudh Rao, Dhiraj Gupta, Professor Gregory Lip

Letter2021

Atrial fibrillation and vascular disease: Coronary artery disease and/or peripheral artery disease?

Hani Essa, Professor Gregory Lip

Article2022

Arterial stiffness and atrial fibrillation: shared mechanisms, clinical implications and therapeutic options

Riccardo Vio, Andrea Silvio Giordani, Maria Stefil, Jillian Madine, Timothy Fairbairn, Sakis Themistoclakis, Paolo Salvi, Alida L.P. Caforio, Alena Shantsila, Eduard Shantsila, Riaz Akhtar, Mark Field, Professor Gregory Lip, Riccardo Proietti